Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Nonstructural Protein Inhibitors. | J Am Chem Soc | 2024 | 39574309 | PubTator, text mining | PubMed |
| Selective protease inhibitors from secondary metabolites of Philippine medicinal plants against porcine epidemic diarrhea virus: A computational veterinary drug discovery approach. | Open Vet J | 2024 | 39553769 | PubTator, text mining | PubMed |
| Sunflower Trypsin Monocyclic Inhibitor Selected for the Main Protease of SARS-CoV-2 by Phage Display. | Biol Pharm Bull | 2024 | 39522974 | PubTator, text mining | PubMed |
| Rapid production of recombinant rotaviruses by overexpression of NSP2 and NSP5 genes with modified nucleotide sequences. | J Virol | 2024 | 39494903 | PubTator, text mining | PubMed |
| PF-00835231 broadly inhibits swine Alpha-coronavirus, including emerging SADS-CoV. | J Virol | 2024 | 39480086 | PubTator, text mining | PubMed |
| MDA5 Is a Major Determinant of Developing Symptoms in Critically Ill COVID-19 Patients. | Clin Rev Allergy Immunol | 2024 | 39460899 | PubTator, text mining | PubMed |
| A Gain-of-Function Cleavage of TonEBP by Coronavirus NSP5 to Suppress IFN-β Expression. | Cells | 2024 | 39404379 | PubTator, text mining | PubMed |
| Inhibition of the SARS-CoV-2 Non-structural Protein 5 (NSP5) Protease by Nitrosocarbonyl-Bases Small Molecules. | ACS Omega | 2024 | 39398138 | PubTator, text mining | PubMed |
| SPECC1 as a pan-cancer biomarker: unraveling its role in drug sensitivity and resistance mechanisms. | Discov Oncol | 2024 | 39397181 | PubTator, text mining | PubMed |
| MERS-CoV-nsp5 expression in human epithelial BEAS 2b cells attenuates type I interferon production by inhibiting IRF3 nuclear translocation. | Cell Mol Life Sci | 2024 | 39395053 | PubTator, text mining | PubMed |
| Unusual BA222-like strains of Rotavirus A (Sedoreoviridae: Rotavirus: Rotavirus A): molecular and genetic analysis based on all genome segments. | Vopr Virusol | 2024 | 39361930 | PubTator, text mining | PubMed |
| SARS-CoV-2 Genotyping Highlights the Challenges in Spike Protein Drift Independent of Other Essential Proteins. | Microorganisms | 2024 | 39338537 | PubTator, text mining | PubMed |
| Phase separation and viral factories: unveiling the physical processes supporting RNA packaging in dsRNA viruses. | Biochem Soc Trans | 2024 | 39324618 | PubTator, text mining | PubMed |
| Full genome sequence analysis of the predominant and uncommon G9P[4] rotavirus strains circulating in Tehran, Iran, 2021-2022: Evidence for inter and intra-genotype recombination. | Virology | 2024 | 39321558 | PubTator, text mining | PubMed |
| Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections. | Nat Commun | 2024 | 39294134 | PubTator, text mining | PubMed |
| PRRSV non-structural protein 5 inhibits antiviral innate immunity by degrading multiple proteins of RLR signaling pathway through FAM134B-mediated ER-phagy. | J Virol | 2024 | 39264156 | PubTator, text mining | PubMed |
| SARS-CoV-2 NSP16 promotes IL-6 production by regulating the stabilization of HIF-1α. | Cell Signal | 2024 | 39251053 | PubTator, text mining | PubMed |
| A Gaussia luciferase reporter assay for the evaluation of coronavirus Nsp5/3CLpro activity. | Sci Rep | 2024 | 39237598 | PubTator, text mining | PubMed |
| E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting proteasome-dependent degradation of NSP5. | J Med Virol | 2024 | 39223933 | PubTator, text mining | PubMed |
| Prochloraz induced alterations in the expression of mRNA in the reproductive system of male offspring mice. | PeerJ | 2024 | 39210919 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=7